TY - JOUR
T1 - Effect of nimodipine, a calcium antagonist, on cerebral vasospasm after subarachnoid hemorrhage in cats
AU - Tanaka, K.
AU - Gotoh, F.
AU - Muramatsu, F.
AU - Fukuuchi, Y.
AU - Okayasu, H.
AU - Suzuki, N.
AU - Kobari, M.
PY - 1982/12/1
Y1 - 1982/12/1
N2 - Effect of a calcium antagonist, isopropyl-(2-methoxyethyl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5- pyridinedicarboxylate (nimodipine) on the cerebral vasospasm after experimental subarachnoid hemorrhage (SAH) was studied in 10 adult cats. The vasospasm was induced by injection of 0.2-0.3 ml fresh autologous whole blood into the cisterna magna. Diameter of pial vessels was continuously measured by means of the vidicon camera system developed in our laboratory. Intravenous administration of nimodipine (0.1 mg/kg) 20-30 min after SAH resulted in a complete disappearance of the spasm with the reduction of blood pressure. The dilatatory response was more marked in the smaller arteries (< 100 μm) than in the larger ones (≥ 100 μm). Administration of a smaller dose of nimodipine (0.01 mg/kg) also produced dilation of the pial vessels, although the effect was less remarkable in the smaller arteries. These data suggest that nimodipine might be useful in the treatment of the cerebral vasospasm after SAH. The mechanism underlying the action of nimodipine was discussed.
AB - Effect of a calcium antagonist, isopropyl-(2-methoxyethyl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5- pyridinedicarboxylate (nimodipine) on the cerebral vasospasm after experimental subarachnoid hemorrhage (SAH) was studied in 10 adult cats. The vasospasm was induced by injection of 0.2-0.3 ml fresh autologous whole blood into the cisterna magna. Diameter of pial vessels was continuously measured by means of the vidicon camera system developed in our laboratory. Intravenous administration of nimodipine (0.1 mg/kg) 20-30 min after SAH resulted in a complete disappearance of the spasm with the reduction of blood pressure. The dilatatory response was more marked in the smaller arteries (< 100 μm) than in the larger ones (≥ 100 μm). Administration of a smaller dose of nimodipine (0.01 mg/kg) also produced dilation of the pial vessels, although the effect was less remarkable in the smaller arteries. These data suggest that nimodipine might be useful in the treatment of the cerebral vasospasm after SAH. The mechanism underlying the action of nimodipine was discussed.
UR - http://www.scopus.com/inward/record.url?scp=0020384512&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020384512&partnerID=8YFLogxK
M3 - Article
C2 - 6891592
AN - SCOPUS:0020384512
SN - 0004-4172
VL - 32
SP - 1529
EP - 1534
JO - Arzneimittel-Forschung/Drug Research
JF - Arzneimittel-Forschung/Drug Research
IS - 12
ER -